Overview

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To obtain a preliminary characterization of the plasma PK and metabolites of actinomycin-D in children with cancer.
Phase:
Phase 4
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
Dactinomycin
Vincristine